Monogram Orthopaedics, Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net loss was USD 3.86 million compared to USD 4.5 million a year ago. Basic loss per share from continuing operations was USD 0.4 compared to USD 0.47 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.88 USD | -3.59% | -3.09% | -45.35% |
May. 01 | Monogram Orthopaedics Inc. Provides Regulatory Update Following Meeting with FDA | CI |
Apr. 12 | Top Premarket Decliners | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-45.35% | 59.47M | |
+10.39% | 126B | |
+2.52% | 8.97B | |
+38.96% | 5.56B | |
-17.50% | 4.99B | |
+8.36% | 3.44B | |
-8.84% | 2.8B | |
-7.52% | 2.18B | |
-3.00% | 2.16B | |
-21.88% | 1.82B |
- Stock Market
- Equities
- MGRM Stock
- News Monogram Orthopaedics, Inc.
- Monogram Orthopaedics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023